Attached files

file filename
8-K - FORM 8-K - Shire plcdp35411_8k.htm
Exhibit 99.01
Press Release

Transaction in Own Shares

January 10, 2013 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”), announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on April 24, 2012 it purchased 154,251 of its ordinary shares of 5 pence each (“Ordinary Shares”) on January 9, 2013. The highest and lowest price paid for the directly acquired Ordinary Shares was 2008.00 pence per share and 1978.00 pence per share respectively.

The purchased shares will be held as treasury shares. Following the above purchase, the Company holds 4,261,111 Ordinary Shares as treasury shares and has 558,289,504 Ordinary Shares in issue (excluding treasury shares).

The purchases were made by an independent third party which makes its trading decisions independently of, and uninfluenced by the Company.  The independence of the third party enables the Company to continue to purchase Ordinary Shares during close periods and other prohibited periods, should they arise. The third party has been appointed by the Company to make purchases to December 31, 2013.

For further information please contact:

Investor Relations
Eric Rojas
+1 781 482 0999
Sarah Elton-Farr
+44 1256 894157

Notes to editors

Shire enables people with life-altering conditions to lead better lives.

Through our deep understanding of patients’ needs, we develop and provide healthcare in the areas of:

Behavioral Health and Gastro Intestinal conditions
Rare Diseases
Regenerative Medicine

as well as other symptomatic conditions treated by specialist physicians.

We aspire to imagine and lead the future of healthcare, creating value for patients, physicians, policymakers, payors and our shareholders.

Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX